• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙戊酸缓释制剂在脑外科手术患者中的药代动力学研究

Pharmacokinetic study of valproic acid sustained-release preparation in patients undergoing brain surgery.

作者信息

Ieiri I, Morioka T, Ichimiya T, Nishio S, Fukui M, Ohtsubo K, Higuchi S

机构信息

Division of Pharmaceutical Science, Kyushu University, Fukuoka, Japan.

出版信息

Ther Drug Monit. 1995 Feb;17(1):6-11. doi: 10.1097/00007691-199502000-00002.

DOI:10.1097/00007691-199502000-00002
PMID:7725378
Abstract

Pharmacokinetics of valproic acid sustained-release preparation (VPA-SR) were studied in nine patients undergoing surgery for brain tumor. Total (t) and free (f) serum concentrations were analyzed in samples drawn during the day of brain surgery and compared with levels from a postoperative day. The area under the curve (AUCt) and clearance (CLt) of the total concentration did not differ on these occasions. In contrast, statistically significant differences were observed in AUCf and CLf between the two occasions; increased AUCf and decreased CLf were observed on the day of surgery. A significant relation was found between the average free fraction (AUCf/AUCt on operation day per AUCf/AUCt on postoperative day) and estimated blood loss during operation (r = 0.82; p < 0.001). In addition, a significant relation was found between simple free fraction and the intraoperative albumin level in serum (r = -0.68; p < 0.001). These findings indicate that the increased VPA free concentration is due to low serum albumin level secondary to blood loss and that there has been a decrease in intrinsic clearance during operation.

摘要

对9例接受脑肿瘤手术的患者研究了丙戊酸缓释制剂(VPA-SR)的药代动力学。在脑手术当天采集的样本中分析了总血清浓度(t)和游离血清浓度(f),并与术后一天的浓度水平进行比较。在这些情况下,总浓度的曲线下面积(AUCt)和清除率(CLt)没有差异。相比之下,两次检测的AUCf和CLf存在统计学显著差异;手术当天观察到AUCf增加和CLf降低。发现平均游离分数(手术日的AUCf/AUCt与术后日的AUCf/AUCt之比)与手术期间估计失血量之间存在显著相关性(r = 0.82;p < 0.001)。此外,发现简单游离分数与血清术中白蛋白水平之间存在显著相关性(r = -0.68;p < 0.001)。这些发现表明,VPA游离浓度增加是由于失血继发的血清白蛋白水平降低,并且手术期间内在清除率有所下降。

相似文献

1
Pharmacokinetic study of valproic acid sustained-release preparation in patients undergoing brain surgery.丙戊酸缓释制剂在脑外科手术患者中的药代动力学研究
Ther Drug Monit. 1995 Feb;17(1):6-11. doi: 10.1097/00007691-199502000-00002.
2
Different serum concentrations of steady-state valproic acid in two sustained-release formulations.
Psychiatry Clin Neurosci. 2007 Jun;61(3):308-12. doi: 10.1111/j.1440-1819.2007.01656.x.
3
The impact of dosage of sustained-release formulation on valproate clearance and plasma concentration in psychiatric patients: analysis based on routine therapeutic drug monitoring data.基于常规治疗药物监测数据的精神科患者丙戊酸清除率和血药浓度与控释制剂剂量的相关性分析。
J Clin Psychopharmacol. 2011 Feb;31(1):115-9. doi: 10.1097/JCP.0b013e318203b405.
4
Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.血清白蛋白、丙戊酸和卡马西平与癌症患者中苯妥英钠药代动力学的相互作用。
Basic Clin Pharmacol Toxicol. 2006 Aug;99(2):133-40. doi: 10.1111/j.1742-7843.2006.pto_309.x.
5
Effect of time, injury, age and ethanol on interpatient variability in valproic acid pharmacokinetics after traumatic brain injury.时间、损伤、年龄和乙醇对创伤性脑损伤后丙戊酸药代动力学患者间变异性的影响。
Clin Pharmacokinet. 2007;46(4):307-18. doi: 10.2165/00003088-200746040-00004.
6
Valproic acid pharmacokinetics in children: III. Very high dosage requirements.
Pediatr Neurol. 1986 Jul-Aug;2(4):202-8. doi: 10.1016/0887-8994(86)90047-0.
7
Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.丙戊酸钠新缓释制剂(丙戊酸缓释颗粒)与现有缓释制剂在每日一次或两次给药后的生物等效性。
Pharmacotherapy. 2005 Jan;25(1):35-41. doi: 10.1592/phco.25.1.35.55626.
8
Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid.左乙拉西坦,一种新型抗癫痫药物:在体外和体内均不存在与丙戊酸的药代动力学相互作用。
Epilepsia. 2003 Feb;44(2):171-8. doi: 10.1046/j.1528-1157.2003.25302.x.
9
A population pharmacokinetic model taking into account protein binding for the sustained-release granule formulation of valproic acid in children with epilepsy.一个考虑蛋白质结合作用的丙戊酸缓释颗粒制剂在癫痫患儿中的群体药代动力学模型。
Eur J Clin Pharmacol. 2018 Jun;74(6):793-803. doi: 10.1007/s00228-018-2444-2. Epub 2018 Mar 21.
10
Effect of unbound clearance on binding parameters of valproic acid to serum proteins.
J Clin Pharmacol. 1993 Feb;33(2):130-5. doi: 10.1002/j.1552-4604.1993.tb03932.x.

引用本文的文献

1
Efficacy, Safety, and Retention Rate of Extended-Release Divalproex Versus Conventional Delayed-Release Divalproex: A Meta-Analysis of Controlled Clinical Trials.缓释丙戊酸二钠与传统缓释丙戊酸二钠的疗效、安全性及保留率:一项对照临床试验的荟萃分析
Front Pharmacol. 2022 Apr 5;13:811017. doi: 10.3389/fphar.2022.811017. eCollection 2022.
2
Conventional and sustained-release valproate in children with newly diagnosed epilepsy: a randomized and crossover study comparing clinical effects, patient preference and pharmacokinetics.新诊断癫痫患儿中常规与缓释丙戊酸盐的比较:一项比较临床效果、患者偏好及药代动力学的随机交叉研究
Eur J Clin Pharmacol. 2006 Oct;62(10):805-15. doi: 10.1007/s00228-006-0175-2. Epub 2006 Aug 2.